# PAVBLU
> **BLA761298** · Biologics License Application · Sponsor: AMGEN INC · Approved 2024-08-23
## Drug
- **FDA Application Number:** BLA761298
- **Application type:** Biologics License Application
- **Brand name:** PAVBLU
- **Generic name:** AFLIBERCEPT-AYYH
- **Active ingredients:** AFLIBERCEPT-AYYH
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AMGEN INC
- **Manufacturer:** Amgen, Inc
- **First approval:** 2024-08-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761298)
---
*MORVS · CC0 1.0*